Quality control of essential drugs (multiple letters) [20]

Lancet

Volumn 350, Issue 9084, 1997, Pages 1106-1107

  Lauridsen, E ^a   Quick, J ^a   Bremer, K ^a   Arya, S C ^a  

^a NONE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; COTRIMOXAZOLE; ESSENTIAL DRUG; PARACETAMOL; RIBOFLAVIN; RIFAMPICIN; DRUG;

DRUG COST; DRUG FORMULATION; DRUG MANUFACTURE; DRUG POTENCY; DRUG QUALITY; GOOD MANUFACTURING PRACTICE; LETTER; PRIORITY JOURNAL; QUALITY CONTROL; DRUG INDUSTRY; NOTE; STANDARD; WORLD HEALTH ORGANIZATION; DRUG CONTROL; MEDICAL LITERATURE;

DRUG INDUSTRY; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL; WORLD HEALTH ORGANIZATION; DRUG AND NARCOTIC CONTROL; PHARMACOPOEIAS AS TOPIC;

EID: 0030868135     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70472-4     Document Type: Letter

References (5)

1. Editorial. Quality control and essential drugs Lancet 350 1997 601
2. Masood E Warnings raised over black market vaccines Nature 374 1995 669
3. Sesay MM Expiry dates on pharmaceuticals—some worrying realities in Sierra Leone Int Pharm J 8 1994 202 206
4. Roy J The menace of substandard drugs World Health Forum 15 1994 406 407
5. Roy J Saha P Sultana S Kenyon AS Rapid screening of marketed paracetamol tablets: use of thin-layer chromatography and a semiquantitatve spot test Bull WHO 75 1997 19 22